The contribution of toll-like receptors to the pathogenesis of asthma

Immunology and Cell Biology

Volumn 85, Issue 6, 2007, Pages 463-470

  Phipps, Simon ^a,b   Lam, Chuan En ^a,b   Foster, Paul S ^a,b,c   Matthaei, Klaus I ^c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c Biology and Environment   (Australia)

Author keywords

Asthma; Pathogenesis; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR;

ALLERGIC DISEASE; ASTHMA; CELLULAR DISTRIBUTION; DENDRITIC CELL; DISEASE EXACERBATION; EOSINOPHIL; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MAST CELL; MICROBIAL CONTAMINATION; NONHUMAN; RESPIRATORY EPITHELIUM; REVIEW; TH2 CELL;

ALLERGENS; ANIMALS; ASTHMA; EPITHELIAL CELLS; HUMANS; MESODERM; RESPIRATORY MUCOSA; TOLL-LIKE RECEPTORS;

EID: 34548448134     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100104     Document Type: Review

References (102)

1. Kay AB. Review articles: advances in immunology: allergy and allergic diseases (first of two parts). N Engl J Med 2001; 344: 30-37.
2. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258-2261.
3. Wills-Karp M, Chiaramonte M. Interleukin-13 in asthma. Curr Opin Pulm Med 2003; 9: 21-27.
4. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779-788.
5. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260.
6. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356: 1723-1727.
7. Wang CC, Nolan TJ, Schad GA, Abraham D. Infection of mice with the helminth Strongyloides stercoralis suppresses pulmonary allergic responses to ovalbumin. Clin Exp Allergy 2001; 31: 495-503.
8. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-1229.
9. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002; 359: 831-834.
10. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002; 19: 68-75.
11. Matricardi PM, Rosmini F, Riondino S, Fortini M, Ferrigno L, Rapicetta M et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000; 320: 412-417.
12. Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 2002; 196: 1381-1386.
13. Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur Respir J 1997; 10: 6-12.
14. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
15. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167: 1882-1885.
16. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and Influenza A virus. J Biol Chem 2005; 280: 5571-5580.
17. Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M et al. Response of human pulmonary epithelial cells to LPS involves toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 2003; 4: 4.
18. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD et al. Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004; 31: 241-245.
19. Hertz CJ, Wu Q, Porter EM, Zhang YJ, Weismuller KH, Godowski PJ et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 2003; 171: 6820-6826.
20. Zhang Z, Louboutin JP, Weiner DJ, Goldberg JB, Wilson JM. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by toll-like receptor 5. Infect Immun 2005; 73: 7151-7160.
21. Platz J, Beisswenger C, Dalpke A, Koczulla R, Pinkenburg O, Vogelmeier C et al. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J Immunol 2004; 173: 1219-1223.
22. Holgate ST, Davies DE, Puddicombe S, Richter A, Lackie P, Lordan J et al. Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma. Eur Respir J Suppl 2003; 44: 24s-29s.
23. Garlanda C, Riva F, Polentarutti N, Buracchi C, Sironi M, De Bortoli M et al. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc Natl Acad Sci USA 2004; 101: 3522-3526.
24. Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, Arditi M. Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem 2005; 280: 5491-5495.
25. Monick MM, Yarovinsky TO, Powers LS, Butler NS, Carter AB, Gudmundsson G et al. Respiratory syncytial virus upregulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem 2003; 17: 17.
26. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201: 937-947.
27. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12: 1023-1026.
28. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4: 63-68.
29. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4: 69-77.
30. Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent toll-like receptor signaling. Nat Immunol 2006; 7: 1074-1081.
31. Xu W, He B, Chiu A, Chadburn A, Shan M, Buldys M et al. Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat Immunol 2007; 8: 294-303.
32. Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 1993; 15: 19-27.
33. Chieppa M, Rescigno M, Huang AY, Germain RN. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med 2006; 203: 2841-2852.
34. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-680.
35. Wang YH, Ito T, Homey B, Watanabe N, Martin R, Barnes CJ et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 2006; 24: 827-838.
36. Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005; 6: 1047-1053.
37. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203: 269-273.
38. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174: 8183-8190.
39. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204: 253-258.
40. Lee HC, Ziegler SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc Natl Acad Sci USA 2007; 104: 914-919.
41. Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, de Waal-Malefyt R et al. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 2003; 197: 1059-1063.
42. Evans MJ, Van Winkle LS, Fanucchi MV, Plopper CG. The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. Am J Respir Cell Mol Biol 1999; 21: 655-657.
43. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 1998; 101: 2129-2139.
44. Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997; 16: 664-673.
45. Phipps S, Benyahia F, Ou TT, Barkans J, Robinson DS, Kay AB. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol 2004; 31: 626-632.
46. Seow CY, Schellenberg RR, Pare PD. Structural and functional changes in the airway smooth muscle of asthmatic subjects. Am J Respir Crit Care Med 1998; 158 (5 Part 3): S179-S186.
47. Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R et al. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol 2006; 118: 641-648.
48. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 2004; 31: 358-364.
49. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 2002; 293: 1364-1369.
50. Groskreutz DJ, Monick MM, Powers LS, Yarovinsky TO, Look DC, Hunninghake GW. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol 2006; 176: 1733-1740.
51. Oliver BG, Johnston SL, Baraket M, Burgess JK, King NJ, Roth M et al. Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respir Res 2006; 7: 71.
52. Shan X, Hu A, Veler H, Fatma S, Grunstein JS, Chuang S et al. Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling. Am J Physiol Lung Cell Mol Physiol 2006; 291: L324-L333.
53. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4CD25 T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033-1036.
54. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6: 135-142.
55. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mastcell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699-1705.
56. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7: 93-104.
57. Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, Ra C et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002; 109: 1351-1359.
58. Varadaradjalou S, Feger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003; 33: 899-906.
59. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004; 114: 174-182.
60. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4: 787-799.
61. Lambrecht BN, Hammad H. The other cells in asthma: dendritic cell and epithelial cell crosstalk. Curr Opin Pulm Med 2003; 9: 34-41.
62. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106: 551-559.
63. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998; 160: 4090-4097.
64. van Rijt LS, Jung S, Kleinjan A, Vos N, Willart M, Duez C et al. In vivo depletion of lung CD11c dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005; 201: 981-991.
65. Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol 2000; 165: 4062-4068.
66. Nagase H, Okugawa S, Ota Y, Yamaguchi M, Tomizawa H, Matsushima K et al. Expression and function of toll-like receptors in eosinophils: activation by toll-like receptor 7 ligand. J Immunol 2003; 171: 3977-3982.
67. Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, Rosenberg HF et al. Eosinophils contribute to innate anti-viral immunity and promote clearance of respiratory syncytial virus. Blood, published online 10 May 2007; doi: 10.1182/blood-2007-01-071340.
68. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969; 89: 422-434.
69. Wardlaw AJ, Kay AB. The role of the eosinophil in the pathogenesis of asthma. Allergy 1987; 42: 321-335.
70. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 651-663.
71. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167: 199-204.
72. Kay AB. The role of eosinophils in the pathogenesis of asthma. Trends Mol Med 2005; 11: 148-152.
73. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195-201.
74. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196: 1645-1651.
75. Piggott DA, Eisenbarth SC, Xu L, Constant SL, Huleatt JW, Herrick CA et al. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J Clin Invest 2005; 115: 459-467.
76. Horner AA, Redecke V, Raz E. Toll-like receptor ligands: hygiene, atopy and therapeutic implications. Curr Opin Allergy Clin Immunol 2004; 4: 555-561.
77. Kaisho T, Hoshino K, Iwabe T, Takeuchi O, Yasui T, Akira S. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int Immunol 2002; 14: 695-700.
78. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947-950.
79. Muraille E, De Trez C, Brait M, De Baetselier P, Leo O, Carlier Y. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J Immunol 2003; 170: 4237-4241.
80. Jankovic D, Kullberg MC, Hieny S, Caspar P, Collazo CM, Sher A. In the absence of IL-12, CD4() T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting. Immunity 2002; 16: 429-439.
81. Barton GM, Medzhitov R. Control of adaptive immune responses by toll-like receptors. Curr Opin Immunol 2002; 14: 380-383.
82. Rudd BD, Schaller MA, Smit JJ, Kunkel SL, Neupane R, Kelley L et al. MyD88-mediated instructive signals in dendritic cells regulate pulmonary immune responses during respiratory virus infection. J Immunol 2007; 178: 5820-5827.
83. Rivera A, Ro G, Van Epps HL, Simpson T, Leiner I, Sant'Angelo DB et al. Innate immune activation and CD4 T cell priming during respiratory fungal infection. Immunity 2006; 25: 665-675.
84. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006; 314: 1936-1938.
85. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 2001; 166: 5688-5694.
86. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002; 169: 6668-6672.
87. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-748.
88. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T et al. Cutting edge: different toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003; 171: 4984-4989.
89. Redecke V, Hacker H, Datta SK, Fermin A, Pitha PM, Broide DH et al. Cutting edge: activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172: 2739-2743.
90. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, Koh A et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004; 172: 4733-4743.
91. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004; 173: 7548-7555.
92. Taylor RC, Richmond P, Upham JW. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol 2006; 117: 1148-1154.
93. Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005; 174: 2942-2950.
94. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Korting HC. Toll-like receptors and innate antifungal responses. Trends Microbiol 2004; 12: 44-49.
95. Yang IA, Fong KM, Holgate ST, Holloway JW. The role of toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol 2006; 6: 23-28.
96. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007; 39: 523-528.
97. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 2004; 101: 3029-3034.
98. Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116: 485-494.
99. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161: 1501-1507.
100. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541-545.
101. Hay DB, Hart BJ, Douglas AE. Effects of the fungus Aspergillus penicillioides on the house dust mite Dermatophagoides pteronyssinus: an experimental re-evaluation. Med Vet Entomol 1993; 7: 271-274.
102. Valerio CR, Murray P, Arlian LG, Slater JE. Bacterial 16S ribosomal DNA in house dust mite cultures. J Allergy Clin Immunol 2005; 116: 1296-1300.